CID-O CLASSIFICAÇõAO INTERNACIONAL DE DOENÇAS PARA ONCOLOGIA
International classification of oncology diseases
No Thumbnail Available
Cite
Pan American Health Organization. (1978). CID-O CLASSIFICAÇõAO INTERNACIONAL DE DOENÇAS PARA ONCOLOGIA [Journal articles]. https://iris.paho.org/handle/10665.2/38624
Date
1978
Document Number
ISBN
eISBN
ISSN
DOI
Other Language Versions
Description
A CLAFFIFICACAO INTERNACIONAL DE DOENCAS PARA ONCOLOGIA (CID-O) E UMA AMPLICAO DO CAPITULO II (NEOPLASMAS) DA NONA REVISAO DA CLASSIFICACAO INTERNACIONAL DE DOENCAS (CID-9). A CID-O PERMITE A CODIFICACA DE TODOS OS NEOPLASMAS POR TOPOGRAFIA, HISTOLOGIA (MORFOLOGIA) E COMPOTA MENTO BIOLOGICO (MALIGNO, BENIGNO, "IN SITU", INCERTO SE BENIGNO OU MALIGNO, E METASTATICO). UM CODIGO PARA GRADUACAO E DIFERENCIACAO HISTOLOGICAS TAMBEN FOI INCLUIDO. ASSIM, A CID-O E UMA NOMENCLATURA CODIFICADA QUE PODE SER USADA, TANTO PARA TOPOGRAFIA COMO PARA TIPOS HISTOLOGICOS DE NEOPLASMAS, POR AQUELES QUE PRETENDAM CODIFICAR COM MAIS PORMENORES QUE OS EXISTENTES NO CAPITULO II DA CID-9. A CID-O NAO PROVE CODIGOS PARA OUTROS TIPOS DE INFORMACA, TAIS COMO ESTADIAMENTO CLINICO, EXTENSAO DA DOENCA, LATERALIDADE, METODO DE DIAGNOSTICO E TRATAMENTO
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
License
Related items
Showing items related by metadata.
Item Digital transformation of mortality reporting using an ICD-11 integrated death certificate system in Suriname(2025-07-28)[ABSTRACT]. The Ministry of Health of Suriname has replaced the outdated 1958 paper-based death certificate with an adapted digital version based on the World Health Organization international form of Medical Certificate of Cause of Death, integrated with the International Classification of Diseases 11th Revision (ICD-11) coding tool. This digital system, which comprises a mobile application and a web-based platform, enables direct selection of diagnoses using the ICD-11 codes, including post-coordination (code combinations) and the use of extension codes. Acting as a centralized hub, it allows the Ministry of Health to efficiently extract and analyze mortality data. Training programs have been provided for all medical doctors to ensure effective adoption. This initiative aligns with the Pan American Health Organization’s Information Systems for Health 2024–2030 strategy, which emphasizes digital transformation to strengthen health systems in the Americas. It also reflects Suriname’s commitment to the 2019 World Health Assembly resolution to adopt ICD-11 as the global standard for cause-of-death reporting. By improving data quality, flow, and accessibility, the system supports timely reporting and reduces workload. Furthermore, it addresses a critical gap, as limited published research exists on the implementation of electronic Medical Certificate of Cause of Death (eMCCD) in the Americas. The system will undergo evaluation after one year to assess its impact and guide further improvements.Item Codificación de mortalidad con CIE-11 en Chile: principales resultados y perspectivas para su implementación(2025-05-08)[RESUMEN]. Objetivo. Evaluar la concordancia, comparabilidad con versión en uso y usabilidad de la Clasificación Internacional de Enfermedades, undécima revisión (CIE-11), que introduce una mayor granularidad, está diseñada para entornos digitales y ofrece mejoras respecto a CIE-10. Método. Se seleccionaron 2 000 certificados médicos de defunción del año 2020 mediante muestreo estratificado proporcional. Dos codificadoras expertas y un equipo gold standard (GS) codificaron los registros con el uso de la herramienta oficial de CIE-11. Se la evaluó la concordancia entre GS y codificadoras expertas en las glosas inmediatas, originarias y la causa básica de defunción (CBD). Se comparó la distribución por capítulos de CIE-11, CIE-10 en la base original y CIE-10 mapeado desde CIE-11. Resultados. La concordancia con precisión clínica varío entre un 37% para la CBD y un 76% para la causa inmediata. La concordancia del código base varió de un 73% para la CBD y un 86% para las causa inmediata y originaria. El índice kappa de Cohen para la CBD fue de 0,68 (IC95%: 0,64 - 0,72) para la codificadora 1 y de 0,76 (IC95%: 0,73 - 0,80) para la codificadora 2, concordancia que se considera sustancial. La distribución de CBD para CIE-10 y para CIE-10 mapeado desde CIE-11 fue similar. Conclusiones. Se observa una adecuada concordancia y comparabilidad de CIE-11, respecto a CIE-10. La usabilidad de la herramienta es alta, lo que confirma la factibilidad de la implementación de CIE-11 en Chile, y subraya la necesidad de capacitación continua y mejoras tecnológicas.Item Maternal mortality in Panama from 1998 to 2022(2024-11-11)[ABSTRACT]. Objective. To examine maternal mortality in Panama, analyzing its direct obstetric deaths, indirect obstetric deaths, and contributory conditions. Methods. This cohort study used publicly available data from the National Institute of Statistics and Census to present a 25-year retrospective analysis of maternal deaths in the Republic of Panama from 1998 to 2022. Public data were sourced from the National Institute of Statistics and Census website of Panama. Relevant codes from the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD) were used. The maternal mortality ratio (MMR) was defined as the number of maternal deaths per 100 000 live births. Trendline reliability with R2 was performed to analyze the data. Results. A total of 1 026 maternal deaths occurred in Panama from 1998 through 2022, of which 61.2% were attributed to direct obstetric causes; 23.9%, indirect obstetric causes; 13.6%, contributory conditions; and 1.4% were unknown or undetermined. The average MMR was 60.1. The trendline reliability resulted in R2 = 0.1 (y = –0.5147x + 1094.7), which is not statistically significant but meets the 2030 Sustainable Development Goals. The specific primary causes of direct obstetric deaths were: 12.9% due to postpartum hemorrhage (ICD O72); 9.2%, eclampsia (ICD O15); 6.7%, puerperal sepsis (ICD O85); and 6.3%, pre-eclampsia (ICD O14). For indirect obstetric deaths, the primary causes were: 14.9% due to other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth, and the puerperium (ICD O99); and 7.3%, maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth, and the puerperium (ICD O98). Conclusions. The findings of this study confirmed that there were substantially more direct obstetric causes (61.2%) than indirect obstetric causes (23.9%), contributory causes (13.6%), or unknown/undetermined causes (1.4%) of maternal mortality, despite being highly preventable. Although Panama is right on track to fulfill the target of 70 MMR by 2030, these results highlight the lack of health care access due to the absence of obstetrician-gynecologists per 100 000 population in indigenous comarcas, where 30.8% of the maternal mortalities occur. Furthermore, the health system in Panama is not immune to pandemics and crises. From 1998 to 2022, there were 5 years when the MMR in Panama exceeded 70: 2001, 2002, 2006, 2011, and 2020. These findings also underscore the dichotomy between statistics and health policy. While the trendline reliability was insignificant (R2 = 0.1), the MMR satisfies requirements for the 2030 Sustainable Development Goals. Future studies should consider factors related to indirect obstetrics and contributory causes of deaths, health care access, COVID-19, cesarean section and natural birth, age, economic income, prenatal and postpartum care, as well as the quality of private and public health facilities in the Americas.Item Panorama da implementação da CID-11 no Brasil(2025-05-12)[RESUMO]. O Brasil iniciou, em 2021, a implementação da 11ª Revisão da Classificação Internacional de Doenças (CID- 11), com término previsto para 2027. A CID-11 representa um salto tecnológico e conceitual que oferece novas oportunidades de análise epidemiológica e de gestão da saúde, porém impõe desafios de interoperabilidade e de preservação das séries históricas que tornam mais complexa a sua implementação. Considerando a grande extensão territorial do Brasil e a existência de sistemas de informação em saúde consolidados, a implementação no país será escalonada, tendo cinco eixos prioritários: publicação, tradução e uso da CID-11 no Brasil; infraestrutura de tecnologia da informação; comparabilidade e qualidade dos dados; desenvolvimento de capacidades; e promoção e disseminação. O presente artigo tem como objetivo apresentar o panorama atual do processo de implantação da CID-11, as etapas já realizadas e as perspectivas futuras. A implementação segue as diretrizes do Guia de Implementação da Organização Mundial da Saúde e a Nota Técnica nº 91/2024 do Ministério da Saúde do Brasil, que aborda procedimentos como a atualização dos sistemas de informação em saúde e áreas de atenção, considerando a diversidade das realidades regionais do país e a magnitude da mudança nas classificações internacionais, com objetivo de garantir segurança e efetividade, com preservação das séries temporais e agilidade para adaptações. O processo representa mais um marco na saúde pública nacional, ao mesmo tempo em que moderniza e aprimora os sistemas de informação de estatísticas vitais, consolidando o papel do Brasil no avanço da saúde pública global.Item The importance of basic and translational research in caring for children with malignant solid tumors in Latin America(2024)[ABSTRACT]. Objective. Basic and translational research in pediatric cancer are essential to improve patient care. To critically assess the developments achieved in these areas in Latin America, we systematically reviewed information published between 2013 and 2023. Methods. Studies of basic and translational research performed by investigators in Latin America evaluating pediatric malignant solid and central nervous system tumors were retrieved from PubMed. Original articles published in English between 2013 and 2023 were included. Collaborations among Latin American authors or among Latin American authors working with researchers from other continents were also included. Studies were excluded if they focused only on adults or on basic research in tumor biology not specifically related to the tumor types analyzed in this review. Results. A total of 550 articles were retrieved, but after removal of duplicates, 514 articles were included in the analysis, the majority of which were authored by researchers affiliated with institutions in Argentina, Brazil and Mexico. These countries also had the highest number of collaborations on original articles published with authors from Europe and North America. Argentina had the highest number of collaborations on original publications, with coauthors from Brazil and Uruguay. The median impact factor of the 244 journals in which articles were published was 3.5. The most commonly studied tumors were osteosarcomas, neuroblastomas and medulloblastomas; the most commonly studied areas were molecular analysis, tumor cell biology and biomarkers. Conclusions. In Latin America, research in pediatric oncology is on the agenda, despite a notable disparity in publication rates and frequency of collaboration between countries. There is a need to strengthen scientific collaboration within Latin America and with countries from other continents to promote research and to develop novel treatment strategies that reflect the local needs of children in Latin America who have solid tumors and brain cancer.